A study identified the mutation mechanism LTA chromothripsis in 50% of high-grade osteosarcoma cases, explaining its genomic ...
Study identifies a novel mechanism driving osteosarcoma and provides insights to help predict patient outcomes ...
LTA, an aerospace research and development company, has taken this to new heights with its prototype, Pathfinder 1, which it tested for the first time in direct sunlight on Nov. 8. “The ...
Hosted on MSN27d
What was that blimp over San Francisco Thursday?The Pathfinder 1 is an experimental blimp built by LTA Research. It has 12 electric motors and is controlled by joystick commands from the pilots in a “Zeppelin-built gondola,” according to ...
The new insights on osteosarcome could, with time, lead to better treatment options and outcomes for patients through more ...
Google cofounder Sergey Brin's airship is ready to take flight. LTA Research, Brin's company that aims to deliver humanitarian aid through "lighter than air" blimp-like vehicles, announced this ...
A new mutation mechanism, called loss-translocation-amplification (LTA) chromothripsis, which is present in approximately 50% of high-grade osteosarcoma cases.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback